Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_05-cv-00802/USCOURTS-caed-2_05-cv-00802-0/pdf.json

Nature of Suit Code: 380
Nature of Suit: Other Personal Property Damage
Cause of Action: 28:1332 Diversity-Property Damage

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Defendant’s fifth counterclaim is for declaratory 1

relief. (First Am. Counterclaim).

1

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

----oo0oo----

ADBAC QUAT JOINT VENTURE,

NO. CIV. S-05-0802 WBS KJM

Plaintiff, 

v. ORDER

RE: MOTION TO DISMISS

QUADEX PHARMACEUTICALS LLC,

and DOES 1-100, inclusive,

Defendants.

----oo0oo----

Pursuant to Federal Rule of Civil Procedure 12(b)(6),

plaintiff moves to dismiss four of the five counterclaims

defendant Quadex Pharmaceuticals LLC asserts. The causes of 1

action plaintiff moves to dismiss are labeled: (1) intentional

interference with prospective economic advantage; (2) negligent

interference with prospective economic advantage; (3) slander;

and (4) defamation. These counterclaims are all based on

plaintiff’s act of petitioning the FDA and threatening to file

Case 2:05-cv-00802-WBS -KJM Document 26 Filed 07/15/05 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

suit and filing suit. (First Am. Counterclaim). 

Defendant has filed a notice of non-opposition to

plaintiff’s motion. Therefore, plaintiff’s motion will be

granted.

IT IS THEREFORE ORDERED that defendant’s counterclaims

for: (1) intentional interference with prospective economic

advantage; (2) negligent interference with prospective economic

advantage; (3) slander; and (4) defamation be, and the same

hereby are, DISMISSED.

DATED: July 14, 2005

Case 2:05-cv-00802-WBS -KJM Document 26 Filed 07/15/05 Page 2 of 2